Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis
Crossref DOI link: https://doi.org/10.1007/s10096-016-2891-6
Published Online: 2017-01-11
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Resch, B.
Bramreiter, V. S.
Kurath-Koller, S.
Freidl, T.
Urlesberger, B.
Funding for this research was provided by:
Medical University of Graz
License valid from 2017-01-11